TI
XBIT icon

Trexquant Investment’s XBiotech XBIT Stock Holding History

Trexquant Investment’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,985
Closed -$45.6K – 1824
2022
Q4 		$45.6K Sell
12,985
-8,990
-41% -$30.7K ﹤0.01% 1324
2022
Q3 		$80K Sell
21,975
-8,994
-29% -$42.3K ﹤0.01% 1291
2022
Q2 		$174K Buy
30,969
+14,069
+83% +$94.7K 0.01% 1383
2022
Q1 		$146K Sell
16,900
-3,748
-18% -$37.6K 0.01% 1250
2021
Q4 		$230K Buy
+20,648
New +$269K 0.01% 1068
2020
Q1 		– Sell
-14,433
Closed -$269K – 1464
2019
Q4 		$269K Buy
+14,433
New +$186K 0.02% 788

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Trexquant Investment's XBIT Position: Q1 2023 in Review

Trexquant Investment sold out of XBiotech (XBIT) in Q1 2023, closing a stake of 12,985 shares — an estimated $45.6K sold.

Trexquant Investment first reported a position in XBIT in Q4 2019 and held it in 6 quarters. The position peaked at $269K in Q4 2019. 38 funds tracked by Wall St. Rank hold XBIT as of Q1 2023.

  • Trexquant Investment reported no remaining XBiotech position as of Q1 2023 after selling out during the quarter.
  • Trexquant Investment sold 12,985 XBiotech shares in Q1 2023, an estimated $45.6K.
  • Trexquant Investment first reported a position in XBiotech in Q4 2019 and held it in 6 quarters.
  • Trexquant Investment's XBiotech position peaked at $269K in Q4 2019.
  • 38 funds tracked by Wall St. Rank held XBiotech as of Q1 2023.

Based on Trexquant Investment's 13F filing for Q1 2023, filed 15 May 2023.